Trials / Sponsors / Redx Pharma Ltd
Redx Pharma Ltd
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary IPF, Fibrosis | Phase 2 | 2022-09-08 |
| Completed | A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therap Advanced Solid Tumours | Phase 2 | 2021-12-10 |
| Completed | A Study to Assess Efficacy of RXC004 +/- Nivolumab in Ring Finger Protein 43 (RNF43) or R-spondin (RSPO) Aberr Colorectal Cancer | Phase 2 | 2021-11-08 |
| Completed | A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy V Fibrosis, Inflammation, Idiopathic Pulmonary Fibrosis | Phase 1 | 2021-05-13 |
| Completed | Study to Evaluate the Safety and Tolerability of RXC004 in Advanced Malignancies Cancer, Solid Tumor | Phase 1 | 2019-03-18 |